Correlation Between Sol Gel and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sol Gel and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sol Gel and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sol Gel Technologies and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Sol Gel and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sol Gel with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sol Gel and Anebulo Pharmaceuticals.
Diversification Opportunities for Sol Gel and Anebulo Pharmaceuticals
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Sol and Anebulo is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Sol Gel Technologies and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Sol Gel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sol Gel Technologies are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Sol Gel i.e., Sol Gel and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sol Gel and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Sol Gel Technologies is expected to generate 6.57 times more return on investment than Anebulo Pharmaceuticals. However, Sol Gel is 6.57 times more volatile than Anebulo Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about 0.1 per unit of risk. If you would invest 47.00 in Sol Gel Technologies on October 15, 2024 and sell it today you would earn a total of 58.00 from holding Sol Gel Technologies or generate 123.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 94.74% |
| Values | Daily Returns |
Sol Gel Technologies vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Sol Gel Technologies |
| Anebulo Pharmaceuticals |
Sol Gel and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sol Gel and Anebulo Pharmaceuticals
The main advantage of trading using opposite Sol Gel and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sol Gel position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.The idea behind Sol Gel Technologies and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |